咨询与建议

限定检索结果

文献类型

  • 1 篇 会议

馆藏范围

  • 1 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 理学
    • 1 篇 物理学
  • 1 篇 工学
    • 1 篇 材料科学与工程(可...
  • 1 篇 医学
    • 1 篇 中西医结合
    • 1 篇 药学(可授医学、理...

主题

  • 1 篇 drug resistance
  • 1 篇 redox-controlled...
  • 1 篇 mesoporous silic...
  • 1 篇 egfr-tki

机构

  • 1 篇 school of life s...
  • 1 篇 key laboratory o...
  • 1 篇 cas center for e...
  • 1 篇 innovation cente...

作者

  • 1 篇 zhanxia zhang
  • 1 篇 hsin-yi huang
  • 1 篇 liu yang
  • 1 篇 hongbin ji
  • 1 篇 yuetong wang

语言

  • 1 篇 英文
检索条件"主题词=Mesoporous silica nano-medicine"
1 条 记 录,以下是1-10 订阅
排序:
Cetuximab-modified mesoporous silica nano-medicine specifically targets EGFR-mutant lung cancer and overcomes drug resistance
Cetuximab-modified mesoporous silica nano-medicine specifica...
收藏 引用
第十三届全国电分析化学学术会议
作者: Yuetong Wang Hsin-Yi Huang Liu Yang Zhanxia Zhang Hongbin Ji Key Laboratory of Systems Biology Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Science CAS center for Excellence in Molecular Cell Science Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Science Innovation Center for Cell Signaling Network Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Science School of Life Science and Technology Shanghai Tech University
Drug resistance to tyrosine kinase inhibitor(TKI) is the main obstacle for efficient treatment of epidermal growth factor receptor(EGFR)-mutant lung cancer *** we design a cetuximab-capped mesoporous silica nanopartic... 详细信息
来源: cnki会议 评论